Clinical Trial Update: Excimer Laser Trabeculostomy Glaucoma Treatment Study [NA]

View source ↗

Summary

Clinical trial update indicates the Excimer Laser Trabeculostomy glaucoma treatment study (NCT04899063) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Primary Open Angle

Drugs mentioned

• Excimer Laser Trabeculostomy (Excimer laser trabeculostomy)

Snippet

Sponsor: Elios Vision, Inc. | Conditions: Glaucoma, Primary Open Angle | NA | Status: COMPLETED